LACTOBACILLUS PLANTARUM CELLS WITH IMPROVED RESISTANCE TO HIGH CONCENTRATIONS OF ETHANOL
The present invention relates to cycloserine resistant mutants of lactic acid bacteria characterized by having improved resistance towards ethanol. The cycloserine resistant mutants of lactic acid bacteria can e.g. be used for malolactic fermentations of wine (i.e. including sparkling wine such as Cava/champagne) having high alcohol levels. Lactic acid bacteria such as As discussed in U.S. Pat. No. 7,625,745 B2 (Danstar Ferment, CH)—in traditional winemaking, the malolactic fermentation (MLF) is produced by means of the spontaneous growth of an indigenous flora of lactic acid bacteria. The process of MLF begins of its own accord, when the malolactic flora is sufficiently developed, that is to say in a random manner between the end of alcoholic fermentation and several weeks, even several months, after the alcoholic fermentation. When the malolactic bacteria reach a concentration of about 106CFU/ml in the medium, they enter an active metabolic phase and start the fermentation of the malic acid. In these conditions, In short, one may say that natural/wildtype U.S. Pat. No. 7,625,745 B2 (PCT filed 2004 and published in 2009) describes the selection of alcohol-resistant It is here relevant to note that in U.S. Pat. No. 7,625,745 B2 a screening was made of natural The isolates of natural lactic acid bacteria were subjected to a selection pressure of resistance to alcohol levels above 10% and two particular D-cycloserine (D-4-amino-isoxazolidone) is an antibiotic which inhibits alanine racemase, D-alanyl-D-alanine ligase, D-alanylalanine synthase and D-alanine permease causing cell lysis. D-alanine racemase is essential for the production of D-alanine, an integral part of the peptidoglycan layer of the cell wall. Strains of It is here relevant to note that above discussed article of Bron et al does not in any way relate to identification of To the knowledge of the present inventors—there is in the prior art not described or suggested any herein relevant link between increased resistance to D-cycloserine and improved resistance to high concentrations of ethanol. The problem to be solved by the present invention is to provide a The The solution is based on that the present inventors have developed a novel selection method for the identification of new improved A novel important step of the herein described new selection method relates to that the present inventors have identified a herein surprisingly relevant link between increased resistance to D-cycloserine and improved resistance to high concentrations of ethanol. Accordingly, the herein described novel selection method may overall be seen as comprising following two steps:
As shown in working Example 3 herein—the present inventors identified that from a pool of D-cycloserine resistant selected Accordingly, the first screening/selection for increased D-cycloserine resistance may, as discussed herein, be seen as a kind of pre-step to rapidly and efficient be able to screen/select/enrich for a As evident to the skilled person—a significant advantage of the herein described screening/selection method is that one relatively rapidly and efficiently is able to screen/select for a For instance, if one already has a As shown in working Example 3 herein—approximately 10% of the first selected D-cycloserine resistant cells were also resistance to relatively high concentrations of ethanol. To the contrary—as shown in working Example 4 herein—by trying to identify an ethanol resistant cell directly from a pool of individual Accordingly, without using the novel screening/selection method as described herein—it would not (or would take a very long time) be possible to identify an ethanol resistant mutant strain of the Without being limited to theory—a theoretical explanation for the herein surprisingly identified and discussed link between increased D-cycloserine resistance and increased ethanol resistance could be that such increased D-cycloserine resistant Similar and without being limited to theory—it could then also be these exopolysaccharides that would protect the As discussed above, the herein identified In the prior art document U.S. Pat. No. 7,625,745 B2 as discussed above—there was not made any herein relevant selection for increased resistance to D-cycloserine. Accordingly, as understood by the skilled person—there is absolutely no reason to believe that any of the Similar, in other above discussed Bron et al., 2002 article—there was not made any herein relevant selection for increased ethanol resistance. Accordingly, as understood by the skilled person—there is absolutely no reason to believe that any of the In summary, it is submitted that the herein relevant discussed Accordingly, a first aspect of the invention relates to a (i): the and (ii): As understood by the skilled person in the present context—the (i): the cells (in point (i) of first aspect) are positively resistant to D-cycloserine in the D-cycloserine resistance assay of example 1; and (ii): the cells (in point (ii) of first aspect) are positively resistant to ethanol in the ethanol resistance assay of example 2. Both the D-cycloserine resistance assay [of point (i)] and ethanol resistance assay [of point (ii)] are based on known, commercially available standard elements (such as e.g. standard media etc). Accordingly, based on the detailed assay description herein (see e.g. example 1 herein for D-cycloserine resistance assay and example 2 herein for ethanol resistance assay) the skilled person is routinely able to repeat these assays to objectively determine whether a specific The novel Further, all other herein relevant steps for making a wine may be done according to the art. Such other wine production relevant steps (e.g. use of yeast cells) are well known routine steps for the skilled person and therefore not necessary to discuss in details herein. Accordingly, a second aspect of the invention relates to a method for producing a wine comprising administering the A third aspect of the invention relates to a method for screening and isolating a novel It is evident to the skilled person that once the inventors herein have disclosed the relevant test assays (i.e. the assays of Examples 1 and 2 herein) it will be routine work for the skilled person to select other new As discussed herein, by using the novel screening/selection method as described herein the inventors have selected and isolated a number of new improved Embodiment of the present invention is described below, by way of examples only. All definitions of herein relevant terms are in accordance of what would be understood by the skilled person in relation to the herein relevant technical context. The term “ The term “ The As known to the skilled person, herein commercially relevant The relevant e.g. 104to 1014CFU/g Accordingly, in an embodiment 104to 1014CFU/g In a preferred embodiment the The term “CFU/g” relates to the gram weight of the composition as such, including suitable relevant additives present in the composition. It does not include the weight of a suitable container used to package the An embodiment relates to that the As known to the skilled person a commercially relevant bacterial composition generally also comprises other relevant suitable additives. Beside the herein relevant Assay to Select for an Increased Resistance to D-cycloserine As discussed above the D-cycloserine resistance assay of point (i) of first aspect is based on known commercially available standard elements (such as e.g. standard media, etc). Accordingly, based on the detailed assay description herein (see e.g. example 1 herein) the skilled person is routinely able to repeat this assay to objectively determine whether a specific cell of interest complies with the D-cycloserine resistance criteria as described in point (i). As discussed above—one may say that the level of resistance as required in the assay of example 1 is a resistance to D-cycloserine that is significantly higher than normally present in natural/wildtype The detailed conditions of example 1 herein is herein a preferred assay to determine if a Increased Resistance to D-cycloserine—Point (i) of First Aspect It may be preferred that the increased resistance to D-cycloserine is higher than the one given in point (i) of the first aspect herein. Accordingly, it may be preferred that the Assay to Select for an Improved Resistance Towards Ethanol As discussed above the ethanol resistance assay of point (ii) of first aspect is based on known commercially available standard elements (such as e.g. standard media, etc). Accordingly, based on the detailed assay description herein (see e.g. example 2 herein) the skilled person is routinely able to repeat this assay to objectively determine whether a specific cell of interest complies with the ethanol resistance criteria as described in point (ii). The detailed conditions of example 2 herein is herein a preferred assay to determine if a Improved Resistance Towards Ethanol—Point (ii) of First Aspect It may be preferred that the improved resistance towards ethanol is higher than the one given in point (ii) of the first aspect herein. Accordingly, it may be preferred that the A Method for Producing a Wine As said above a second aspect of the invention relates to a method for producing a wine comprising administering the The wine may be any wine of interest such as red wine, white wine or sparkling wine such as Cava/champagne. As know to the skilled person—for commercial relevant wine production there is generally administrated around Accordingly, in a preferred embodiment of the method of the second aspect of the invention—there is administrated from 104CFU to 108CFU A Method for Cocoa Bean Fermentation As known in the art— In line of this—a herein relevant use of the A Method for Silage Production As known in the art— In line of this—a herein relevant use of the A Method for Screening and Isolating a Novel As said above, the third aspect relates to a method for screening and isolating a novel In the method of the third aspect, a As understood by the skilled person, the specific herein detailed described D-cycloserine resistance and ethanol resistance assays (see e.g. example 1 herein for D-cycloserine resistance assay and example 2 herein for ethanol resistance assay) parameters may be changed to make a alternative screening method that still obtains the main goals as described herein, i.e. a Without being limited to theory—it could maybe be possible to use a functionally equivalent antibiotic to D-cycloserine as a selective agent to get the increased resistance to D-cycloserine of point (i) of the first aspect. In the present context, the term “functionally equivalent antibiotic” should be understood as an antibiotic with the same mode of action or the same target as D-cycloserine, such as e.g. other inhibitors of D-alanyl-D-alanine ligases, such as e.g. vancomycin and other inhibitors of D-alanine racemase, such as e.g. O-carbamoyl-D-serine, alaphosphin and the haloalanines. For instance, without being limited to theory—it could maybe be possible to use the functionally equivalent antibiotic vancomycin as the selective pressure agent and thereby get selected strains that are vancomycin resistant and then maybe also resistant to D-cycloserine as discussed herein (i.e. a As evident to the skilled person—the end result of step (b) is the isolation of a novel Accordingly, a separate aspect of the invention relates to a It is evident that this novel Step (a) of the method for screening and isolating a novel As known—it is routine work for the skilled person to make/create such a pool of individual It may e.g. be made from a suitable preferred starting cell, which may be subjected to suitable mutagenesis (e.g. using a chemical mutagen or UV mutagenesis) to make a pool of mutants of said starting cell—i.e. to create a pool of individual As discussed in working Example 3 herein—the starting Alternatively, one could e.g. start from cells already made to have herein relevant resistance to D-cycloserine—such as e.g. Relevant Medium: The medium is the known Grape Juice GJ-5 medium described in column 20, lines 10 to 20 of U.S. Pat. No. 7,112,346 (Chr. Hansen A/S). As described in lines 10 to 20 of U.S. Pat. No. 7,112,346—the GJ-5 medium has the following composition:
As known to the skilled person—this GJ-5 medium is a medium that is considered to be representative for a grape juice used for wine production. Further, as understood by the skilled person in the present context—a grape juice concentrate is a standard well known ingredient of such a medium. In the present context and as understood by the skilled person—the specific Grape juice concentrate may be supplied from different suppliers and independently of the specific supplier one will (within standard measurement uncertainty) get the same herein relevant result of cycloserine resistance for a herein relevant cell of interest. A After the 24 hours growth is OD600measured for all samples. A Cells that are capable of complying with this increased resistance to D-cycloserine criteria are herein defined as cells that are positively resistant to D-cycloserine in the D-cycloserine resistance assay of this example 1. Conclusion: Based on the Cycloserine resistance Selection assay of this Example 1—for a specific strain of interest (e.g. one from a relevant commercial product)—the skilled person can routinely test if this specific strain of interest has the herein relevant Cycloserine resistance. Medium: The medium is the standard GJ-5 medium as used in Example 1 above. A Cells that are capable of complying with this improved resistance towards ethanol criteria are herein defined as cells that are positively resistant to ethanol in the ethanol resistance assay of this example 2. Conclusion: Based on the Ethanol resistance assay of this Example 2—for a specific strain of interest (e.g. one from a relevant commercial product)—the skilled person can routinely test if this specific strain of interest has the herein relevant Ethanol resistance. Strains Mutant Isolation Measured according to Example 1 above— Accordingly, In order to isolate mutants of the Surviving cells were diluted and plated on GJ-5 plates (without D-cycloserine) and colonies were screened in microtiter plates for the ability to grow in the presence of various concentrations of D-cycloserine in the range of 25-100 μg/ml D-cycloserine in GJ-5 medium. 25% of the resulting colonies were identified as fast growers in the presence of D-cycloserine—i.e. they were positively resistant to D-cycloserine in the D-cycloserine resistance assay of example 1. These mutants were chosen for further study. The selected D-cycloserine resistant mutants were further purified and tested for their ability to grow in GJ-5 added various concentrations of ethanol in the range 5-14% ethanol or wine at 18° C. and 25° C. During this screening it was observed that approximately 10% of the mutants were more resistant to high concentrations of ethanol. Two mutant derivatives of CHCC14158, designated CHCC14255 and CHCC14254, were significantly more resistant to high concentrations of ethanol than the mother strain when the growth was compared in GJ-5 at 25° C. in the presence of 11, 12 and 13 ethanol of parental strain CHCC14158 and two cycloserine resistant mutants CHCC14255 and CHCC14254. The two cycloserine resistant mutants CHCC14255 and CHCC14254 could both grow to an OD600of at least 0.8 after 3 days incubation at 25° C. in the GJ-5 medium with 11% ethanol—for CHCC14255 the OD600was more than 1—i.e. both strains were positively resistant to ethanol in the ethanol resistance assay of this example 2. The starting CHCC14158 strain could only grow to an OD600of around 0.65—i.e. the starting CHCC14158 strain was not positively resistant to ethanol in the ethanol resistance assay of this example 2. The cycloserine resistance of both the CHCC14255 and CHCC14254 mutants was tested according to Example 1 above and both positively had the required increased resistance to D-cycloserine as required in Example 1. For CHCC14255 the amount of D-cycloserine that reduces the OD600measured growth with 50% in GJ-5 medium as compared to the growth rate in GJ-5 medium without D-cycloserine (i.e. with 0 μg/ml D-cycloserine) was around 100 μg/ml D-cycloserine (see For CHCC14254 the amount of D-cycloserine that reduces the OD600measured growth with 50% in GJ-5 medium as compared to the growth in GJ-5 medium without D-cycloserine (i.e. with 0 μg/ml D-cycloserine) was around 100 μg/ml D-cycloserine (see UV mutagenesis was done on a It is a strain with similar properties to Screening for ethanol was done as in Example 3 above—however, after analysis of more than 100 different mutants/colonies it was not possible to select a mutant with improved resistance towards ethanol as defined in Example 2 above. 1: U.S. Pat. No. 7,625,745 B2 (Danstar Ferment, CH) 2: Bron et al., 2002 Appl Environ Microbiol. 68:5663-5670 3: U.S. Pat. No. 7,112,346 (Chr. Hansen A/S) Cycloserine resistant mutants of lactic acid bacteria characterized by having improved resistance towards ethanol. The cycloserine resistant mutants of lactic acid bacteria can e.g. be used for malolactic fermentations of wine (i.e. including sparkling wine such as Cava/champagne) having high alcohol levels. 1. A (i): the (ii): 2. The 3. The 4. The 5. A method for producing a wine comprising administering the 6. The method for producing a wine of 7. The method for producing a wine of 8. A method for cocoa bean fermentation, wherein the 9. A method for silage production, wherein the 10. A method for screening and isolating a novel (a): selecting and isolating from a pool of individual (b): selecting and isolating—from the selected pool of 11. The (i): the cells (in point (i) of (ii): the cells (in point (ii) of FIELD OF THE INVENTION
BACKGROUND ART
SUMMARY OF THE INVENTION
DEFINITIONS
DRAWINGS
DETAILED DESCRIPTION OF THE INVENTION
EXAMPLES
Example 1
Cycloserine Resistance Selection Assay
Example 2
Ethanol Screening Resistance Assay
Example 3
Use of D-cycloserine to Isolate Mutants of
Example 4
Reference/Control Experiment
REFERENCES